what icd-10 code covers psa for medicare

Is a PSA test covered by Medicare?

Prostate Specific Antigen National Coverage Determination (PSA), Total . Medicare Limited Coverage Tests – Covered Diagnosis Codes Source: National Coverage Determinations Coding Policy Manual and Change Report (ICD-10-CM) January 2017 Effective January 1, 2017 Medicare Limited Coverage Tests. CPT Code: 84153 . Code Description

What diagnosis code will cover a PSA?

Prostate Specific Antigen (PSA) ICD 10 Codes that Meed Medical Necessity Proprietary Information of UnitedHealthcare Community and State. Copyright 2018 United Healthcare Services, Inc. Unit Codes: CPT Code: 16100 84153 37740 PSA ICD-10 Codes Covered if selection criteria are met: C61 MALIGNANT NEOPLASM OF PROSTATE C67.5 MALIGNANT NEOPLASM …

What diagnosis codes are covered by Medicare?

To view the complete policy and the full list of codes, please refer to the CMS website reference 84153 Prostate Specific Antigen PSA Coverage Indications, Limitations, and/or Medical Necessity Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer.

What is covered under each part of Medicare?

Covered ICD-10 Codes. ICD-10 Descriptor C61 Malignant neoplasm of prostate C67.5 Malignant neoplasm of bladder neck C77.4 Sec and unsp malig neoplasm of inguinal and lower limb nodes C77.5 Secondary and unsp malignant neoplasm of intrapelv nodes C77.8 Sec and unsp malig neoplasm of nodes of multiple regions C79.51 Secondary malignant neoplasm of bone

What is a PSA test?

PSA is of proven value in differentiating benign from malignant disease in men with lower urinary tract signs & symptoms (e.g., hematuria, slow urine stream, hesitancy, urgency, frequency, nocturia & incontinence) as well as with patients with palpably abnormal prostate glands on physician exam, and in patients with other laboratory or imaging studies that suggest the possibility of a malignant prostate disorder . PSA is also a marker used to follow the progress of prostate cancer once a diagnosis has been established, such as detecting metastatic or persistent disease in patients who may require additional treatment. PSA testing may also be useful in the differential diagnosis of men presenting with as yet undiagnosed disseminated metastatic disease.

What is prostate specific antigen?

Description: Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer. Three to 6 months after radical prostatectomy, PSA is reported to provide a sensitive indicator of persistent disease. Six months following introduction of antiandrogen therapy, PSA is reported of distinguishing patients with favorable response from those in whom limited response is anticipated.

Description Information

Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Coding Analyses for Labs (CALs)

This NCD has been or is currently being reviewed under the National Coverage Determination process. The following are existing associations with CALs, from the Coding Analyses for Labs database.

What is the ICd 10 code for prostate cancer?

Elevated prostate specific antigen [PSA] 1 R97.20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM R97.20 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of R97.20 - other international versions of ICD-10 R97.20 may differ.

Is R97.20 a valid justification for admission to an acute care hospital?

R97.20 is not usually sufficient justification for admission to an acute care hospital when used a principal diagnosis. The following code (s) above R97.20 contain annotation back-references. Annotation Back-References.

How often is a PSA test covered by Medicare?

Screening PSA tests are covered at a frequency of once every 12 months for men who have attained age 50 (i.e., starting at least one day after they have attained age 50), if at least 11 months have passed following the month in which the last Medicare-covered screening prostate specific antigen test was performed.

What is the code for prostate cancer screening?

Screening PSAs. Submit HCPCS code G0103 for screening PSA tests. Medicare coverage for screening PSAs is limited to once every 12 months.

What is prostate specific antigen?

Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer. Three to 6 months after radical prostatectomy, PSA is reported to provide a sensitive indicator of persistent disease.

What is a PSA test?

Diagnostic PSA tests are defined as those performed when the patient has signs or symptoms. If a patient has no signs or symptoms of prostate cancer, submit the appropriate code for a screening PSA. If a patient does have signs or symptoms of prostate cancer, submit the appropriate code for a diagnostic PSA.

Does Medicare cover prostate cancer screening?

Medicare allows for coverage of both screening and diagnostic Prostate Specific Antigen (PSA) tests. Screening PSA tests are defined as those that are performed in the absence of signs or symptoms of prostate cancer. Diagnostic PSA tests are defined as those performed when the patient has signs or symptoms.

What is the code for prostate cancer screening?

Some payers, including Medicare, have different coding requirements for screening and diagnostic PSA tests. For a Medicare patient, report a screening PSA with G0103 Prostate cancer screening; prostate specific antigen test (PSA) and a diagnostic PSA with one of the following three codes (based on the type of test): ...

What is the diagnosis code for malignant neoplasm of prostate?

For a screening test for a patient with no signs or symptoms of disease, use diagnosis code Z12.5 Encounter for screening for malignant neoplasm of prostate. If you report another diagnosis code with G0103, Medicare will not pay for it. You must use a screening diagnosis with a screening CPT® code.

What happens if you don't have a PSA?

Prostate specific antigen (PSA) screenings are commonplace in most urology practices, which means if you don’t have your procedure and diagnosis coding straight, you may face high denial rates and possibly significant revenue loss. Avoid those pitfalls with these three tips.

Do you have to check the PSA code before submitting a claim?

Once you decide on the codes , there’s one more point to check before submitting the claim: Payers have tight restrictions on the frequency for which they will pay for PSA tests.

Do you need modifier 25 for PSA?

You should not need modifier 25 Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service on the E/M service, as a global period does not apply to the PSA laboratory test.

Can a urologist report PSA test?

If the urologist performs a separate evaluation and management (E/M) service during the same encounter as the PSA test, you should be able to separately report the PSA test code and the appropriate E/M code (based on the documented level of service).